摘要
肺表面活性物质(pulmonary surfactant,PS)是急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS)的治疗手段之一,但治疗效果尚不明确。相关研究表明,不同种类的PS、给药剂量、给药方式等因素均可能影响PS使用效果。该文对PS治疗ARDS的研究现状进行概述。
Pulmonary surfactant(PS)is one of the treatments for acute respiratory distress syndrome(ARDS),but the curative effect is still unsure. The results of current studies indicate that different kinds,doses and delivery methods of PS may affect the outcomes. This paper makes a review of the current status of PS in the treatment of ARDS.
作者
李科纯
钱素云
曾健生
LI Ke-chun;Q;ZENG Jian-sheng(Pediatric Intensive Care Unit (PICU), Beijing Children' s Hospital, Capital Medical University, Beijing 100045, China)
出处
《中国实用儿科杂志》
CSCD
北大核心
2018年第6期431-434,共4页
Chinese Journal of Practical Pediatrics
基金
吴阶平医学基金会临床科研专项资助基金(320.6750.17192)